
|Articles|November 1, 2000
Supplements and Featured Publications
- Clinical and Economic Impact of Low-Molecular Weight Heparins in Managed Care
- Volume 6
- Issue 20 Suppl
Overview of Enoxaparin in the Treatment of DVT
Author(s)Steven R. Deitcher, MD
Advertisement
Articles in this issue
over 25 years ago
Participating Facultyover 25 years ago
Introductionover 25 years ago
DVT and Pulmonary Embolism in the Perioperative Patientover 25 years ago
CME/CPE Article: Economics of Low-Molecular Weight Heparinsover 25 years ago
CME/CPE Quizover 25 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
2
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
5










